Accord Healthcare, Inc. recalls Atropine Sulfate Injection, USP 8 mg per 20 mL (0.4 mg per mL), 20 mL Multiple Dose Vials, Rx only, Manufactured for: A
Recalled July 19, 2023 · FDA recall D-0917-2023 · Accord Healthcare
Hazard
Presence of Particulate Matter: Particulate matter identified as fiber. · FDA Class II
Units
2348 vials
Sold at
Nationwide within the United States
Description
Presence of Particulate Matter: Particulate matter identified as fiber.
Product
Atropine Sulfate Injection, USP 8 mg per 20 mL (0.4 mg per mL), 20 mL Multiple Dose Vials, Rx only, Manufactured for: Accord Healthcare, Inc. Durham, NC 27703 Manufactured by: Intas Pharmaceuticals Limited Ahmedabad-382 210, India, NDC 16729-512-43.
Manufacturer(s)
Accord Healthcare, Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →